# A Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SYH2085

> **NCT07412353** · PHASE1 · RECRUITING · sponsor: **CSPC ZhongQi Pharmaceutical Technology Co., Ltd.** · enrollment: 74 (estimated)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** SYH2085
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07412353
- **Lead sponsor:** CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-12
- **Primary completion:** 2026-11-12
- **Final completion:** 2026-12-31
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07412353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07412353, "A Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SYH2085". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07412353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*